Imalumab
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 20, 2015 (NCT02448810)
Timeline
Indications
Mechanism of action
MIF inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4650294 ↗
Also known as
- bax69
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02540356 | Phase 1/Phase 2 (Phase 2) | Nov 2, 2015 | Baxalta |
| NCT02448810 | Phase 2 | May 20, 2015 | Baxalta |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baxalta | For profit | 2 | 2 | 1 | 2015 |
1 organizations
Page 1 / 1